Metomidate
 | |
| Systematic (IUPAC) name | |
|---|---|
|
methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number |
5377-20-8  |
| ATCvet code | QN05CM94(WHO) |
| PubChem | CID 21474 |
| ChemSpider |
20182  |
| UNII |
Z18ZYL8Y51 |
| ChEMBL |
CHEMBL494039 |
| Chemical data | |
| Formula | C13H14N2O2 |
| Molar mass | 230.263 g/mol |
| |
| |
| (what is this?) (verify) | |
Metomidate is a non-barbiturate imidazole that was discovered by Janssen Pharmaceutica in 1965[1] and under the names (Hypnodil, Nokemyl) is sold as a sedative-hypnotic drug used in Europe to treat humans and for veterinary purposes.[2]
11C-labelled metomidate (11C-metomidate), may be used with positron emission tomography (PET). For instance, to detect tumors of adrenocortical origin.[3][4]
See also
References
- ↑ BE Patent 662474
- ↑ Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 683. ISBN 978-3-88763-075-1. Retrieved 27 October 2011.
- ↑ Khan TS; Sundin A; Juhlin C; Långström B; et al. (2003). "11C-metomidate PET imaging of adrenocortical cancer". European Journal of Nuclear Medicine and Molecular Imaging 30 (3): 403–410. doi:10.1007/s00259-002-1025-9. PMID 12634969.
- ↑ Minn H; Salonen A; Friberg J; Roivainen A; et al. (June 2004). "Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG". J. Nucl. Med. 45 (6): 972–9. PMID 15181132.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.